ArticleDiscover oncology2025
Mapping the landscape of locally advanced colon cancer research: a 30-year bibliometric perspective.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Our study aimed to perform a comprehensive bibliometric analysis to investigate the evolution of research in locally advanced colon cancer (LACC) over the past 30 years. This study examined 206 articles from the Science Citation Index Expanded within the Web of Science database, spanning from 1991 to 2023. It encompassed a detailed review of publication trends, geographic distribution, institutional contributions, authorship patterns, and keyword analysis. Publications in LACC research saw a substantial increase in publications starting in 2016, with China emerging as the primary contributor, followed by the USA and Japan. Our analysis revealed a shift in research focus from traditional management to advanced treatment approaches, including neoadjuvant therapy and complete mesocolic excision. Keywords, such as "carcinomatosis", "systemic chemotherapy", and "cytoreductive surgery" have become prominent, reflecting evolving research hotspots. However, the low centrality among top authors indicates a preference for independent research over collaborative efforts. This bibliometric study highlights significant advancements and shifts in LACC research over the last 30 years, highlighting an increasing focus on advanced therapeutic approaches. Enhancing international collaboration is essential to enhance LACC research, potentially improving treatments and patient outcomes. Our study provides a foundational reference for guiding future research and fostering collaborative efforts in the field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.